Cases & Deals

Pfizer acquires PowderMed

Clients Pfizer, Inc.

Jones Day represented Pfizer in its acquisition of PowderMed Ltd., a privately held UK company specializing in the development of DNA-based vaccines.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.